CEMO Pharma is a pharmaceutical company created in 2007. Initially, the company was authorized by the French Medicine Agency to perform the distribution of Investigational Medicinal Products (IMPs)1. Since January 2010, CEMO Pharma has the status of Importer, Manufacturer and Distributor of IMPs.
CEMO Pharma is an affiliate of CEMO (www.cemo.fr), CRO involved in clinical trial logistics.
Our company manages medicines, medical devices and dietary supplements tested in clinical studies; it takes advantages of a strong know-how in international clinical trials.
CEMO Pharma offers different services:
- IMPD2 writing,
- Import of IMPs,
- Management of manufacturing operations carried out on the IMP,
- Management of control analysis carried out on IMP,
- Secondary packaging and labeling, blinding of products,
- QP release of IMPs, GMP compliance confirmation,
- Distribution, exportation,
Facilities are secured (alarm, limited access area).
Pharmacists are permanently available in case of emergency.
1 Directive 2001/20/EC, Article 2 (d), provides the following definition for an IMP: “a pharmaceutical form of an active substance or placebo being tested or used as a reference in a clinical trial, including products already with a marketing authorization but used or assembled (formulated or packaged) in a way different from the authorized form, or when used for an unauthorised indication, or when used to gain further information about the authorised form.”
2 Investigational Medicinal Product Dossier.